Common variants on chromosome 6p22.1 are associated with schizophrenia.
paper
Cited
Public
- Authors
- Shi, Jianxin; Levinson, Douglas F; Duan, Jubao; Sanders, Alan R; Zheng, Yonglan; Pe'er, Itsik; Dudbridge, Frank; Holmans, Peter A; Whittemore, Alice S; Mowry, Bryan J; Olincy, Ann; Amin, Farooq; Cloninger, C Robert; Silverman, Jeremy M; Buccola, Nancy G; Byerley, William F; Black, Donald W; Crowe, Raymond R; Oksenberg, Jorge R; Mirel, Daniel B; Kendler, Kenneth S; Freedman, Robert; Gejman, Pablo V
- Year
- 2009
- Journal
- Nature
- PMID
- 19571809
- DOI
- 10.1038/nature08192
- PMCID
- PMC2775422
Schizophrenia, a devastating psychiatric disorder, has a prevalence of 0.5-1%, with high heritability (80-85%) and complex transmission. Recent studies implicate rare, large, high-penetrance copy number variants in some cases, but the genes or biological mechanisms that underlie susceptibility are not known. Here we show that schizophrenia is significantly associated with single nucleotide polymorphisms (SNPs) in the extended major histocompatibility complex region on chromosome 6. We carried out a genome-wide association study of common SNPs in the Molecular Genetics of Schizophrenia (MGS) case-control sample, and then a meta-analysis of data from the MGS, International Schizophrenia Consortium and SGENE data sets. No MGS finding achieved genome-wide statistical significance. In the meta-analysis of European-ancestry subjects (8,008 cases, 19,077 controls), significant association with schizophrenia was observed in a region of linkage disequilibrium on chromosome 6p22.1 (P = 9.54 x 10(-9)). This region includes a histone gene cluster and several immunity-related genes--possibly implicating aetiological mechanisms involving chromatin modification, transcriptional regulation, autoimmunity and/or infection. These results demonstrate that common schizophrenia susceptibility alleles can be detected. The characterization of these signals will suggest important directions for research on susceptibility mechanisms.
Chromosome 6p22.1 Genetic association and linkage disequilibrium results in European-ancestry samplesGenome-wide significant evidence for association (P < 5 Γ 10β8, threshold shown by solid red line, SNPs by large red diamonds) was observed at 7 SNPs across 209 kb. P-values are shown for all genotyped and imputed SNPs (25,900,000β27,875,000 bp) for the meta-analysis of European-ancestry MGS, ISC and SGENE samples (8,008 cases, 19,077 controls). Red circles indicate other SNPs with P < 5 Γ 10β7. Not shown are two SNPs in HLA-DQA1 (6p21.32; lowest P = 6.88 Γ 10β8, 32,710,247 bp; see Supplementary Datafile 1). Locations are shown for RefSeq genes and POM121L2. Pairwise LD relationships are shown for 26 SNPs with P < 10β7 (except that SNPs 5 and 6 are shown, despite slightly larger P-values, to illustrate LD for that segment; and a SNP in strong LD with SNPs 25 and 26 is omitted). LD was computed from MGS European-ancestry genotyped and imputed SNP data. The signal is poorly localized because of strong LD: of the 7 significant SNPs, 7β8 and 9β11 are in nearly perfect LD; they are in or within ~ 30β50 kb of a cluster of 5 histone genes (HIST1H2BJ, HIST1H2AG, HIST1H2BK, HIST1H4I, HIST1H2AH; 27,208,073β27,223,325 bp). These SNPs are in moderately strong LD (r2 = 0.52β0.77) with 2 other significant SNPs 70β140 kb away, upstream of PRSS16 (SNP 13) or between PRSS16 and POM121L2 (SNP18). (See Table 2 and Supplementary Figures S10β11 for additional details.)
1β3 of 3
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Biological insights into schizophrenia from ancestrally diverse populations. | Bigdeli TB et al. | β | 2026 | β |
| Immunogenetic Variants in Major Mental and Neurodevelopmental Disorders. | Le Clerc S et al. | β | 2026 | β |
| Long read and preliminary pangenome analyses reveal breed-specific structural variations and novel sequences in Holstein and Jersey cattle. | Gao Y et al. | β | 2026 | β |
| Phased-assembly-driven pangenome graphs for structural variant genotyping and complex trait mapping in dairy cattle. | Yang L et al. | β | 2026 | β |
| Relevance of polymorphisms in TLR2/4 genes and their association with plasma cytokines for schizophrenia. | Patlola SR et al. | β | 2026 | β |
| SNP-based prediction of schizophrenia using machine learning. | Ramazanova Z et al. | β | 2026 | β |
| Aberrant Expression of TH2LCRR and GATA3 in Peripheral Blood Mononuclear Cells of Patients with Acute-Phase Schizophrenia: Integrative Bioinformatics Analysis and Experimental Study. | Moghiseh E et al. | β | 2025 | β |
| Chronic inflammation response as a key factor in polycystic ovary syndrome among patients with bipolar disorder. | Liu J et al. | β | 2025 | β |
| Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms. | Chen X et al. | β | 2025 | β |
| Divergent changes in complement pathway gene expression in schizophrenia and bipolar disorder: Links to inflammation and neurogenesis in the subependymal zone. | Sager REH et al. | β | 2025 | β |
| From variants to mechanisms: Neurogenomics in the post-GWAS era. | Margolis MP et al. | β | 2025 | β |
| Genomic Analysis of Trichotillomania. | Halvorsen MW et al. | β | 2025 | β |
| GRPa-PRS: A risk stratification method to identify genetically-regulated pathways in polygenic diseases. | Li X et al. | β | 2025 | β |
| Identification and validation of depression-associated genetic variants in the UK Biobank cohort with transcriptome and DNA methylation analyses in independent cohorts. | Lafta MS et al. | β | 2025 | β |
| Identification of Schizophrenia-Risk Regulatory Variant rs1399178 in the Non-coding Region With Its Impact on NRF1 Binding. | Ji L et al. | β | 2025 | β |
| Inflammation manipulation and a complement-centered reboot of the Toxoplasma gondii model of schizophrenia. | Xiao J et al. | β | 2025 | β |
| Investigating the relationship between toll-like receptor activity, low-grade inflammation and cognitive deficits in schizophrenia patients - A mediation analysis. | Patlola SR et al. | β | 2025 | β |
| Longitudinal analysis of proinflammatory and anti-inflammatory cytokines in the cerebrospinal fluid and peripheral blood of treatment-naΓ―ve first-episode psychosis patients, and their correlation with psychosis severity and cognitive impairment in sub-Saharan Africa. | Thela L et al. | β | 2025 | β |
| Molecular and Functional Analysis of TLR 1, 2 and 6 in Peripheral Blood Monocytes of Patients with Schizophrenia: A Pilot Study. | Sotelo-RamΓrez CE et al. | β | 2025 | β |
| PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia. | Kozlova A et al. | β | 2025 | β |
| Psychiatric genetics in the diverse landscape of Latin American populations. | Bruxel EM et al. | β | 2025 | β |
| Tensor decomposition of multi-dimensional splicing events across multiple tissues to identify splicing-mediated risk genes associated with complex traits. | Yan Y et al. | β | 2025 | β |
| The expanding spectrum of infectious risk organisms and immunogenetic susceptibility in neuropsychiatric disorders. | Debnath M | β | 2025 | β |
| The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective. | Su BW et al. | β | 2025 | β |
| A comprehensive update on genetic inheritance, epigenetic factors, associated pathology, and recent therapeutic intervention by gene therapy in schizophrenia. | R R et al. | β | 2024 | β |
| Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia. | Wang R et al. | β | 2024 | β |
| Association between schizophrenia and psoriasis: A two-sample bidirectional Mendelian randomization study. | Ou Y et al. | β | 2024 | β |
| Association between the <i>HHEX</i> polymorphism and delayed memory in first-episode schizophrenic patients. | Zhu ZH et al. | β | 2024 | β |
| Association study of the complement component C4 gene and suicide risk in schizophrenia. | Ebrahimi M et al. | β | 2024 | β |
| Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia. | Leung PBM et al. | β | 2024 | β |
| Decreased serum VEGF and NRG1Ξ²1 levels in male patients with chronic schizophrenia: VEGF correlation with clinical symptoms and cognitive deficits. | Chen P et al. | β | 2024 | β |
| Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with Schizophrenia. | Wang J et al. | β | 2024 | β |
| Epidemiological and Genetic Analyses of Schizophrenia and Breast Cancer. | Tang M et al. | β | 2024 | β |
| Genetic contribution to microglial activation in schizophrenia. | Koskuvi M et al. | β | 2024 | β |
| Linking Polygenic Risk of Schizophrenia to Variation in Magnetic Resonance Imaging Brain Measures: A Comprehensive Systematic Review. | Jameei H et al. | β | 2024 | β |
| Methylome-wide and meQTL analysis helps to distinguish treatment response from non-response and pathogenesis markers in schizophrenia. | Polakkattil BK et al. | β | 2024 | β |
| Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells. | Muhtaseb AW et al. | β | 2024 | β |
| Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics. | Shen HP et al. | β | 2024 | β |
| Scaled and Efficient Derivation of Loss of Function Alleles in Risk Genes for Neurodevelopmental and Psychiatric Disorders in Human iPSC | Zhang H et al. | β | 2024 | β |
| Scaled and efficient derivation of loss-of-function alleles in risk genes for neurodevelopmental and psychiatric disorders in human iPSCs. | Zhang H et al. | β | 2024 | β |
| Schizophrenia and Bone Marrow Disorders: An Emerging Clinical Association. | Jayakumar J et al. | β | 2024 | β |
| Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches toΒ insights of susceptibility genes. | Lv Y et al. | β | 2024 | β |
| Structure-function coupling changes in first-episode, treatment-naΓ―ve schizophrenia correlate with cell type-specific transcriptional signature. | Yao G et al. | β | 2024 | β |
| The complement system in neurodegenerative and inflammatory diseases of the central nervous system. | Negro-Demontel L et al. | β | 2024 | β |
| The complement system in neurodegenerative diseases. | Nimmo J et al. | β | 2024 | β |
| The predictive capacity of polygenic risk scores for disease risk is only moderately influenced by imputation panels tailored to the target population. | Levi H et al. | β | 2024 | β |
| Therapeutic potential of gamma entrainment using sensory stimulation for cognitive symptoms associated with schizophrenia. | Black T et al. | β | 2024 | β |
| The Traf2 and NcK interacting kinase inhibitor NCB-0846 suppresses seizure activity involving the decrease of GRIA1. | Wang M et al. | β | 2024 | β |
| Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis. | Patlola SR et al. | β | 2023 | β |
| Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial. | Susai SR et al. | β | 2023 | β |
| Brain Lipids and Lipid Droplet Dysregulation in Alzheimer's Disease and Neuropsychiatric Disorders. | Zhao X et al. | β | 2023 | β |
| Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases. | Santiago JA et al. | β | 2023 | β |
| Common genetic variants contribute to heritability of age at onset of schizophrenia. | Sada-Fuente E et al. | β | 2023 | β |
| Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics. | Batista-Brito R et al. | β | 2023 | β |
| Effects of MAP4K inhibition on neurite outgrowth. | Lasham DJ et al. | β | 2023 | β |
| Epigenome-Wide Analysis of DNA Methylation and Optimism in Women and Men. | Wang C et al. | β | 2023 | β |
| Excitatory Dysfunction Drives Network and Calcium Handling Deficits in 16p11.2 Duplication Schizophrenia Induced Pluripotent Stem Cell-Derived Neurons. | Parnell E et al. | β | 2023 | β |
| Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity. | Soheili-Nezhad S et al. | β | 2023 | β |
| Genetic Influences on Cognitive Dysfunction in Schizophrenia. | Greenwood TA | β | 2023 | β |
| Genome-wide association study identifies four pan-ancestry loci for suicidal ideation in the Million Veteran Program. | Ashley-Koch AE et al. | β | 2023 | β |
| HERV-W ENV Induces Innate Immune Activation and Neuronal Apoptosis via linc01930/cGAS Axis in Recent-Onset Schizophrenia. | Li X et al. | β | 2023 | β |
| Lipid-correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia. | Arihisa W et al. | β | 2023 | β |
| Longitudinal study of inflammation and relapse in schizophrenia. | Miller BJ et al. | β | 2023 | β |
| MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets. | Zhang HC et al. | β | 2023 | β |
| Schizophrenia as autoimmune disease: Involvement of Anti-NCAM antibodies. | Khlidj Y et al. | β | 2023 | β |
| Schizophrenia, Human Leukocyte Antigen (HLA), and Herpes Viruses: Immunogenetic Associations at the Population Level. | James LM et al. | β | 2023 | β |
| Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case-control association study. | Mukhopadhyay A et al. | β | 2023 | β |
| Social isolation-induced transcriptomic changes in mouse hippocampus impact the synapse and show convergence with human genetic risk for neurodevelopmental phenotypes. | Laighneach A et al. | β | 2023 | β |
| The genetic architecture of schizophrenia: review of large-scale genetic studies. | Kato H et al. | β | 2023 | β |
| Analysis of the association between MICA gene polymorphisms and schizophrenia. | Ren X et al. | β | 2022 | β |
| An ErbB4-Positive Neuronal Network in the Olfactory Bulb for Olfaction. | Tan Z et al. | β | 2022 | β |
| Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank. | O'Connell KS et al. | β | 2022 | β |
| Chromatin modifier developmental pluripotency associated factor 4 (DPPA4) is a candidate gene for alcohol-induced developmental disorders. | Auvinen P et al. | β | 2022 | β |
| Contribution from MHC-Mediated Risk in Schizophrenia Can Reflect a More Ethnic-Specific Genetic and Comorbid Background. | Srinivas L et al. | β | 2022 | β |
| Epigenetics and first-episode psychosis: A systematic review. | Lockwood L et al. | β | 2022 | β |
| Evidence that the pituitary gland connects type 2 diabetes mellitus and schizophrenia based on large-scale trans-ethnic genetic analyses. | Cai L et al. | β | 2022 | β |
| Genome-Wide Causation Studies of Complex Diseases. | Jiao R et al. | β | 2022 | β |
| Genomics, convergent neuroscience and progress in understanding autism spectrum disorder. | Willsey HR et al. | β | 2022 | β |
| Homotypic and heterotypic <i>in cis</i> associations of MHC class I molecules at the cell surface. | Ruggiero FM et al. | β | 2022 | β |
| Imprecise Predictive Coding Is at the Core of Classical Schizophrenia. | Liddle PF et al. | β | 2022 | β |
| Infection Polygenic Factors Account for a Small Proportion of the Relationship Between Infections and Mental Disorders. | Shorter JR et al. | β | 2022 | β |
| Interferon-Ξ³ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression. | Pavlinek A et al. | β | 2022 | β |
| Loss of function of OTUD7A in the schizophrenia- associated 15q13.3 deletion impairs synapse development and function in human neurons. | Kozlova A et al. | β | 2022 | β |
| Network reconstruction for trans acting genetic loci using multi-omics data and prior information. | Hawe JS et al. | β | 2022 | β |
| Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. | Ji E et al. | β | 2022 | β |
| Psoriasis and medical ramifications: A comprehensive analysis based on observational meta-analyses. | Zhou Y et al. | β | 2022 | β |
| Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom. | Li J et al. | β | 2022 | β |
| The schizophrenia-associated missense variant rs13107325 regulates dendritic spine density. | Li S et al. | β | 2022 | β |
| Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. | Dash S et al. | β | 2022 | β |
| ZNF204P is a stemness-associated oncogenic long non-coding RNA in hepatocellular carcinoma. | Hwang JH et al. | β | 2022 | β |
| A polygenic resilience score moderates the genetic risk for schizophrenia. | Hess JL et al. | β | 2021 | β |
| Artificial image objects for classification of schizophrenia with GWAS-selected SNVs and convolutional neural network. | Chen X et al. | β | 2021 | β |
| Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. | Nemani K et al. | β | 2021 | β |
| Association study between genetic variants and the risk of schizophrenia in the Chinese population based on GWAS-implicated 6p21.3-23.1 human genome region: a case-control study. | Li G et al. | β | 2021 | β |
| A systematic review and meta-analysis of imaging genetics studies of specific reading disorder. | Thomas T et al. | β | 2021 | β |
| Bench Research Informed by GWAS Results. | Kondratyev NV et al. | β | 2021 | β |
| Cell type-specific and cross-population polygenic risk score analyses of <i>MIR137</i> gene pathway in schizophrenia. | Yao Y et al. | β | 2021 | β |
| Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived <i>NRXN1</i>-mutant neurons. | Pak C et al. | β | 2021 | β |
| Crystal structure of the GTP-binding protein-like domain of AGAP1. | Cheng N et al. | β | 2021 | β |
| Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes. | Druart M et al. | β | 2021 | β |
| Genetic architecture of schizophrenia: a review of major advancements. | Legge SE et al. | β | 2021 | β |
| Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans. | Bigdeli TB et al. | β | 2021 | β |
| Glyoxalase 1 Confers Susceptibility to Schizophrenia: From Genetic Variants to Phenotypes of Neural Function. | Yin J et al. | β | 2021 | β |
| HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder. | Boukouaci W et al. | β | 2021 | β |
| Immune system regulation and role of the human leukocyte antigen in posttraumatic stress disorder. | Katrinli S et al. | β | 2021 | β |
| Infections, antibiotic treatment and the Microbiome in relation to schizophrenia. | Klein-Petersen AW et al. | β | 2021 | β |
| <i>NLRP3</i> Influences Cognitive Function in Schizophrenia in Han Chinese. | Liu R et al. | β | 2021 | β |
| Mendelian randomization integrating GWAS and eQTL data revealed genes pleiotropically associated with major depressive disorder. | Yang H et al. | β | 2021 | β |
| Meta-Analysis of Joint Test of SNP and SNP-Environment Interaction with Heterogeneity. | Jin Q et al. | β | 2021 | β |
| MHC class I H2-Kb negatively regulates neural progenitor cell proliferation by inhibiting FGFR signaling. | Lin K et al. | β | 2021 | β |
| MicroRNAs in the Onset of Schizophrenia. | Thomas KT et al. | β | 2021 | β |
| Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome. | Hwang H et al. | β | 2021 | β |
| Neuroinflammation in schizophrenia: the role of nuclear factor kappa B. | Murphy CE et al. | β | 2021 | β |
| New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction. | Izuo N et al. | β | 2021 | β |
| nMAGMA: a network-enhanced method for inferring risk genes from GWAS summary statistics and its application to schizophrenia. | Yang A et al. | β | 2021 | β |
| Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. | Δ½uptΓ‘k M et al. | β | 2021 | β |
| Prenatal origins of neuropsychiatric diseases. | Amgalan A et al. | β | 2021 | β |
| Resolving cell state in iPSC-derived human neural samples with multiplexed fluorescence imaging. | Tomov ML et al. | β | 2021 | β |
| Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation. | Chen P et al. | β | 2021 | β |
| Systematic discovery of signaling pathways linking immune activation to schizophrenia. | Gao Y et al. | β | 2021 | β |
| Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia. | Chen YM et al. | β | 2021 | β |
| Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. | Tamouza R et al. | β | 2021 | β |
| Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank. | Sandoval-Plata G et al. | β | 2021 | β |
| Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants. | Zhang S et al. | β | 2020 | β |
| An integrative gene network-based approach to uncover the cellular and molecular infrastructures of schizophrenia. | Bozorgmehr A et al. | β | 2020 | β |
| A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function. | Mondanelli G et al. | β | 2020 | β |
| Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia. | Buchanan RW et al. | β | 2020 | β |
| Association between a <i>TCF4</i> Polymorphism and Susceptibility to Schizophrenia. | Gao JY et al. | β | 2020 | β |
| Common variants in FAN1, located in 15q13.3, confer risk for schizophrenia and bipolar disorder in Han Chinese. | Jian X et al. | β | 2020 | β |
| Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry. | Bigdeli TB et al. | β | 2020 | β |
| Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders. | Perrone MG et al. | β | 2020 | β |
| Deciphering microbiome and neuroactive immune gene interactions in schizophrenia. | Severance EG et al. | β | 2020 | β |
| Differential gene regulatory pattern in the human brain from schizophrenia using transcriptomic-causal network. | Yazdani A et al. | β | 2020 | β |
| Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder. | Miller BJ et al. | β | 2020 | β |
| From Infection to the Microbiome: An Evolving Role of Microbes in Schizophrenia. | Severance EG et al. | β | 2020 | β |
| Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. | Chen J et al. | β | 2020 | β |
| Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits. | Goldsmith DR et al. | β | 2020 | β |
| Interferon-Ξ³ signaling in human iPSC-derived neurons recapitulates neurodevelopmental disorder phenotypes. | Warre-Cornish K et al. | β | 2020 | β |
| Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells. | Powell SK et al. | β | 2020 | β |
| Machine learning analysis of exome trios to contrast the genomic architecture of autism and schizophrenia. | Sardaar S et al. | β | 2020 | β |
| Neurocognitive and neurophysiological endophenotypes in schizophrenia: An overview. | Donati FL et al. | β | 2020 | β |
| Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders. | Kokkosis AG et al. | β | 2020 | β |
| Personality traits in psychosis and psychosis risk linked to TSPO expression: a neuroimmune marker. | Gerritsen C et al. | β | 2020 | β |
| Polygenic Risk Scores for Subtyping of Schizophrenia. | Chen J et al. | β | 2020 | β |
| Robust kernel association testing (RobKAT). | Martinez K et al. | β | 2020 | β |
| Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. | Zamanpoor M | β | 2020 | β |
| The complement system in schizophrenia: where are we now and what's next? | Woo JJ et al. | β | 2020 | β |
| The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer's Disease and Major Neuropsychiatric Disorders. | Butler Iii RR et al. | β | 2020 | β |
| The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation. | Comer AL et al. | β | 2020 | β |
| WITHDRAWN: Genetics of Parkinson's disease. | Lill CM | β | 2020 | β |
| Activity-dependent modulation of hippocampal synaptic plasticity via PirB and endocannabinoids. | Djurisic M et al. | β | 2019 | β |
| A de novo 2q37.2 deletion encompassing AGAP1 and SH3BP4 in a patient with autism and intellectual disability. | Pacault M et al. | β | 2019 | β |
| A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. | Solberg DK et al. | β | 2019 | β |
| A flexible and parallelizable approach to genome-wide polygenic risk scores. | Newcombe PJ et al. | β | 2019 | β |
| Association Study of the Complement Component C4 Gene in Tardive Dyskinesia. | Zai CC et al. | β | 2019 | β |
| Beyond genome-wide significance: integrative approaches to the interpretation and extension of GWAS findings for alcohol use disorder. | Salvatore JE et al. | β | 2019 | β |
| Biological and practical implications of genome-wide association study of schizophrenia using Bayesian variable selection. | Rowe B et al. | β | 2019 | β |
| Case Report of Childhood-Onset Psychosis in a Patient with a Known WNT10A Mutation. | Kobza AO et al. | β | 2019 | β |
| Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study. | Cao B et al. | β | 2019 | β |
| Deconvolution of transcriptional networks identifies TCF4 as a master regulator in schizophrenia. | Doostparast Torshizi A et al. | β | 2019 | β |
| Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders. | Wilkinson B et al. | β | 2019 | β |
| Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms. | Greenwood TA et al. | β | 2019 | β |
| From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies. | Duan J et al. | β | 2019 | β |
| GWAS of Behavioral Traits. | Mehta D et al. | β | 2019 | β |
| Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder. | Rodriguez N et al. | β | 2019 | β |
| Identification of genes related to mental disorders by text mining. | Wu Y et al. | β | 2019 | β |
| Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia. | Zhao L et al. | β | 2019 | β |
| Intrinsic and extrinsic mechanisms of synapse formation and specificity in C. elegans. | Hendi A et al. | β | 2019 | β |
| Mega-analysis of Odds Ratio: A Convergent Method for a Deep Understanding of the Genetic Evidence in Schizophrenia. | Jia P et al. | β | 2019 | β |
| Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap. | Kimoto S et al. | β | 2019 | β |
| Patients with psoriasis have a higher risk of schizophrenia: A systematic review and meta-analysis of observational studies. | Ungprasert P et al. | β | 2019 | β |
| Preventing discrimination based on psychiatric risk biomarkers. | Brannan C et al. | β | 2019 | β |
| Reduced cortical thickness related to single nucleotide polymorphisms in the major histocompatibility complex region in antipsychotic-naive schizophrenia. | Tao B et al. | β | 2019 | β |
| Robust Reference Powered Association Test of Genome-Wide Association Studies. | Wang Y et al. | β | 2019 | β |
| SLC39A8 is a risk factor for schizophrenia in Uygur Chinese: a case-control study. | Jian X et al. | β | 2019 | β |
| SummaryAUC: a tool for evaluating the performance of polygenic risk prediction models in validation datasets with only summary level statistics. | Song L et al. | β | 2019 | β |
| TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. | Gumina V et al. | β | 2019 | β |
| The Association Between Schizophrenia Risk Variants and Creativity in Healthy Han Chinese Subjects. | Wang D et al. | β | 2019 | β |
| Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire. | Guerder S et al. | β | 2019 | β |
| Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines. | Hood VL et al. | β | 2019 | β |
| Translational bioinformatics in mental health: open access data sources and computational biomarker discovery. | Tenenbaum JD et al. | β | 2019 | β |
| Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. | Prata DP et al. | β | 2019 | β |
| Association study of NDST3 gene for schizophrenia, bipolar disorder, major depressive disorder in the Han Chinese population. | Wang L et al. | β | 2018 | β |
| Autoimmune phenotypes in schizophrenia reveal novel treatment targets. | Severance EG et al. | β | 2018 | β |
| Can prebiotics assist in the management of cognition and weight gain in schizophrenia? | Kao AC et al. | β | 2018 | β |
| Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes. | Yang CP et al. | β | 2018 | β |
| Convergent roles of de novo mutations and common variants in schizophrenia in tissue-specific and spatiotemporal co-expression network. | Jia P et al. | β | 2018 | β |
| Corticostriatal circuit defects in Hoxb8 mutant mice. | Nagarajan N et al. | β | 2018 | β |
| C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review. | Fond G et al. | β | 2018 | β |
| Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. | Lesh TA et al. | β | 2018 | β |
| Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery. | Kos MZ et al. | β | 2018 | β |
| Gene-environment interaction and psychiatric disorders: Review and future directions. | Assary E et al. | β | 2018 | β |
| Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation. | Donohoe G et al. | β | 2018 | β |
| Imaging genetics of schizophrenia in the post-GWAS era. | Arslan A | β | 2018 | β |
| Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. | Miller BJ et al. | β | 2018 | β |
| Interaction between BDNF and TNF-Ξ± genes in schizophrenia. | Zhang Y et al. | β | 2018 | β |
| Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges. | Arslan A | β | 2018 | β |
| Meta-Analysis of Cytokine and Chemokine Genes in Schizophrenia. | Hudson ZD et al. | β | 2018 | β |
| MHC class I in dopaminergic neurons suppresses relapse to reward seeking. | Murakami G et al. | β | 2018 | β |
| Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study. | Prasad KM et al. | β | 2018 | β |
| Prediction of Schizophrenia Diagnosis by Integration of Genetically Correlated Conditions and Traits. | Chen J et al. | β | 2018 | β |
| Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation? | Fitzgerald E et al. | β | 2018 | β |
| The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders. | Xiao X et al. | β | 2018 | β |
| The immunogenetics of neurological disease. | Misra MK et al. | β | 2018 | β |
| The promoter polymorphisms in HTR2A gene associated with schizophrenia in Chinese of Han ethnicity. | Sun Q et al. | β | 2018 | β |
| Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model. | Duan J et al. | β | 2018 | β |
| Two distinct ontogenies confer heterogeneity to mouse brain microglia. | De S et al. | β | 2018 | β |
| A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia. | Fischer EK et al. | β | 2017 | β |
| A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen. | Chen X et al. | β | 2017 | β |
| Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia. | Rowland LM et al. | β | 2017 | β |
| Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia: A meta-analysis of case-control studies. | Feng Y et al. | β | 2017 | β |
| Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. | Hartz SM et al. | β | 2017 | β |
| Association of NKAPL, TSPAN18, and MPC2 gene variants with schizophrenia based on new data and a meta-analysis in Han Chinese. | Li Z et al. | β | 2017 | β |
| Attempts to replicate genetic associations with schizophrenia in a cohort from north India. | Prasad S et al. | β | 2017 | β |
| Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population. | Yu H et al. | β | 2017 | β |
| Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits. | Batista-Brito R et al. | β | 2017 | β |
| Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophrenia. | McLean RT et al. | β | 2017 | β |
| Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms. | McGregor C et al. | β | 2017 | β |
| Evaluation of shared genetic susceptibility loci between autoimmune diseases and schizophrenia based on genome-wide association studies. | Hoeffding LK et al. | β | 2017 | β |
| Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data. | Malavia TA et al. | β | 2017 | β |
| Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics. | Giegling I et al. | β | 2017 | β |
| Genetics of Schizophrenia: Overview of Methods, Findings and Limitations. | Henriksen MG et al. | β | 2017 | β |
| Genetics of Schizophrenia: Ready to Translate? | Foley C et al. | β | 2017 | β |
| Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. | Li Z et al. | β | 2017 | β |
| Genome-Wide Association Study of Male Sexual Orientation. | Sanders AR et al. | β | 2017 | β |
| Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis. | Blokland GAM et al. | β | 2017 | β |
| Identification of commonly altered genes between in major depressive disorder and a mouse model of depression. | Yamagata H et al. | β | 2017 | β |
| <i>Erbb4</i> Deletion from Medium Spiny Neurons of the Nucleus Accumbens Core Induces Schizophrenia-Like Behaviors via Elevated GABA<sub>A</sub> Receptor Ξ±1 Subunit Expression. | Geng HY et al. | β | 2017 | β |
| Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [<sup>18</sup>F]FEPPA. | Hafizi S et al. | β | 2017 | β |
| Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [<sup>18</sup>F]FEPPA. | Hafizi S et al. | β | 2017 | β |
| Immature morphological properties in subcellular-scale structures in the dentate gyrus of Schnurri-2 knockout mice: a model for schizophrenia and intellectual disability. | Nakao A et al. | β | 2017 | β |
| Influence of <i>CFH</i> gene on symptom severity of schizophrenia. | Zhang C et al. | β | 2017 | β |
| Integration of expression quantitative trait loci and pleiotropy identifies a novel psoriasis susceptibility gene, PTPN1. | Yin X et al. | β | 2017 | β |
| Integration of gene expression and methylation to unravel biological networks in glioblastoma patients. | Gadaleta F et al. | β | 2017 | β |
| Large-scale interaction effects reveal missing heritability in schizophrenia, bipolar disorder and posttraumatic stress disorder. | Woo HJ et al. | β | 2017 | β |
| LLR: a latent low-rank approach to colocalizing genetic risk variants in multiple GWAS. | Liu J et al. | β | 2017 | β |
| Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain. | Andriani GA et al. | β | 2017 | β |
| New insights into the understanding of MHC associations with immune-mediated disorders. | Caillat-Zucman S | β | 2017 | β |
| No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes. | Johnson EC et al. | β | 2017 | β |
| Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci. | Forrest MP et al. | β | 2017 | β |
| Progress in genome-wide association studies of schizophrenia in Han Chinese populations. | Yue W et al. | β | 2017 | β |
| Risk of developing psoriasis in patients with schizophrenia: a nationwide retrospective cohort study. | Yu S et al. | β | 2017 | β |
| Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia. | Volk DW | β | 2017 | β |
| Schizophrenia genetics in the genome-wide era: a review of Japanese studies. | Kanazawa T et al. | β | 2017 | β |
| [Search for risk genes in schizophrenia]. | Rujescu D | β | 2017 | β |
| Sleep and inflammatory markers in different psychiatric disorders. | Krysta K et al. | β | 2017 | β |
| SZDB: A Database for Schizophrenia Genetic Research. | Wu Y et al. | β | 2017 | β |
| The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies. | Ellul P et al. | β | 2017 | β |
| The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions. | Chang H et al. | β | 2017 | β |
| Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions. | Miller BJ et al. | β | 2017 | β |
| Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis. | Sanders AR et al. | β | 2017 | β |
| Urinary tract infections in children and adolescents with acute psychosis. | Carson CM et al. | β | 2017 | β |
| Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia. | Sharma RP et al. | β | 2016 | β |
| A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. | Li M et al. | β | 2016 | β |
| Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia. | Wu JQ et al. | β | 2016 | β |
| Altered neural signaling and immune pathways in peripheral blood mononuclear cells of schizophrenia patients with cognitive impairment: A transcriptome analysis. | Wu JQ et al. | β | 2016 | β |
| Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study. | Lizano PL et al. | β | 2016 | β |
| An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. | Hannon E et al. | β | 2016 | β |
| Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls. | Hoseth EZ et al. | β | 2016 | β |
| Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China. | Yang G et al. | β | 2016 | β |
| Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. | Severance EG et al. | β | 2016 | β |
| Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics. | Schmitt A et al. | β | 2016 | β |
| Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation. | Butler MG et al. | β | 2016 | β |
| Designing penalty functions in high dimensional problems: The role of tuning parameters. | Chen TH et al. | β | 2016 | β |
| Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function. | Guan F et al. | β | 2016 | β |
| Evaluation of voltage-dependent calcium channel Ξ³ gene families identified several novel potential susceptible genes to schizophrenia. | Guan F et al. | β | 2016 | β |
| From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. | Cariaga-Martinez A et al. | β | 2016 | β |
| Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. | Greenwood TA et al. | β | 2016 | β |
| Genetic Evaluation of Schizophrenia Using the Illumina HumanExome Chip. | Moons T et al. | β | 2016 | β |
| Genetics of Parkinson's disease. | Lill CM | β | 2016 | β |
| Genetics of Schizophrenia: Historical Insights and Prevailing Evidence. | van de Leemput J et al. | β | 2016 | β |
| Identification of Phosphorylation Consensus Sequences and Endogenous Neuronal Substrates of the Psychiatric Risk Kinase TNIK. | Wang Q et al. | β | 2016 | β |
| Immaturity of brain as an endophenotype of neuropsychiatric disorders. | Hagihara H et al. | β | 2016 | β |
| Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study. | Prins BP et al. | β | 2016 | β |
| In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [<sup>11</sup>C](R)-PK11195 positron emission tomography study. | Holmes SE et al. | β | 2016 | β |
| Is it time for immunopsychiatry in psychotic disorders? | Leboyer M et al. | β | 2016 | β |
| Is there a role for immune-to-brain communication in schizophrenia? | Khandaker GM et al. | β | 2016 | β |
| KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. | Johnson EO et al. | β | 2016 | β |
| Mapping inflammation onto mood: Inflammatory mediators of anhedonia. | Swardfager W et al. | β | 2016 | β |
| Neuroimmune biomarkers in schizophrenia. | Tomasik J et al. | β | 2016 | β |
| Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates. | Prasad KM et al. | β | 2016 | β |
| No association between schizophrenia susceptibility variants and macroscopic structural brain volume variation in healthy subjects. | Li M et al. | β | 2016 | β |
| Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia. | Li H et al. | β | 2016 | β |
| Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population. | Wen Z et al. | β | 2016 | β |
| Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. | Srinivas L et al. | β | 2016 | β |
| Replication of genome-wide association study (GWAS) susceptibility loci in a Latino bipolar disorder cohort. | Gonzalez S et al. | β | 2016 | β |
| Role of Immune and Autoimmune Dysfunction in Schizophrenia. | Severance EG et al. | β | 2016 | β |
| Schizophrenia risk from complex variation of complement component 4. | Sekar A et al. | β | 2016 | β |
| The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin. | Arnold M et al. | β | 2016 | β |
| The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders. | Severance EG et al. | β | 2016 | β |
| The <i>NCAN</i> gene: schizophrenia susceptibility and cognitive dysfunction. | Wang P et al. | β | 2016 | β |
| The Major Histocompatibility Complex (MHC) in Schizophrenia: A Review. | Mokhtari R et al. | β | 2016 | β |
| The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophrenia. | Miyashita M et al. | β | 2016 | β |
| Two-stage additional evidence support association of common variants in the HDAC3 with the increasing risk of schizophrenia susceptibility. | Jia X et al. | β | 2016 | β |
| Type I bHLH Proteins Daughterless and Tcf4 Restrict Neurite Branching and Synapse Formation by Repressing Neurexin in Postmitotic Neurons. | D'Rozario M et al. | β | 2016 | β |
| Utility and validity of DISC1 mouse models in biological psychiatry. | Tomoda T et al. | β | 2016 | β |
| What role does inflammation play in schizophrenia? | MΓΌller N | β | 2016 | β |
| Whole-Genome Sequencing of a Healthy Aging Cohort. | Erikson GA et al. | β | 2016 | β |
| Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data. | Shi J et al. | β | 2016 | β |
| Abnormal immune system development and function in schizophrenia helps reconcile diverse findings and suggests new treatment and prevention strategies. | Anders S et al. | β | 2015 | β |
| A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia. | Le Clerc S et al. | β | 2015 | β |
| A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. | Perez-Andreu V et al. | β | 2015 | β |
| ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan. | Lee SY et al. | β | 2015 | β |
| A molecular pathway analysis informs the genetic background at risk for schizophrenia. | Crisafulli C et al. | β | 2015 | β |
| An evaluation of association between common variants in C4BPB/C4BPA genes and schizophrenia. | Wang S et al. | β | 2015 | β |
| ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice. | DelestrΓ© L et al. | β | 2015 | β |
| A schizophrenia-associated HLA locus affects thalamus volume and asymmetry. | Brucato N et al. | β | 2015 | β |
| Association analysis of the HLA-DRB1*01 and HLA-DRB1*04 with schizophrenia by tag SNP genotyping in the Japanese population. | Ratta-apha W et al. | β | 2015 | β |
| Association of common variants in H2AFZ gene with schizophrenia and cognitive function in patients with schizophrenia. | Chang M et al. | β | 2015 | β |
| Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population. | Kimura H et al. | β | 2015 | β |
| Association study of H2AFZ with schizophrenia in a Japanese case-control sample. | Jitoku D et al. | β | 2015 | β |
| Clinical and parental age characteristics of rare copy number variant burden in patients with schizophrenia. | Martin AK et al. | β | 2015 | β |
| Collective effects of SNPs on transgenerational inheritance in Caenorhabditis elegans and budding yeast. | Zhu Z et al. | β | 2015 | β |
| Common variants of IRF3 conferring risk of schizophrenia. | Li X et al. | β | 2015 | β |
| Comparing schizophrenia symptoms in the Iban of Sarawak with other populations to elucidate clinical heterogeneity. | McLean D et al. | β | 2015 | β |
| Convergence of advances in genomics, team science, and repositories as drivers of progress in psychiatric genomics. | Lehner T et al. | β | 2015 | β |
| Developmental expression and localization of MHC class I molecules in the human central nervous system. | Zhang A et al. | β | 2015 | β |
| Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study. | Prasad KM et al. | β | 2015 | β |
| DNA methylation differences in monozygotic twin pairs discordant for schizophrenia identifies psychosis related genes and networks. | Castellani CA et al. | β | 2015 | β |
| ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia. | Perez-Garcia CG | β | 2015 | β |
| Evaluating historical candidate genes for schizophrenia. | Farrell MS et al. | β | 2015 | β |
| Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia. | Ingason A et al. | β | 2015 | β |
| Further evidence supporting the association of NKAPL with schizophrenia. | Wang Z et al. | β | 2015 | β |
| Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls. | CalabrΓ² M et al. | β | 2015 | β |
| Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. | Andreassen OA et al. | β | 2015 | β |
| Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. | Hall J et al. | β | 2015 | β |
| Genetics of complex traits in psychiatry. | Gelernter J | β | 2015 | β |
| Genetic studies of schizophrenia: an update. | Chen J et al. | β | 2015 | β |
| Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. | Peprah E et al. | β | 2015 | β |
| Genome-wide scan demonstrates significant linkage for male sexual orientation. | Sanders AR et al. | β | 2015 | β |
| Identification and functional characterization of rare SHANK2 variants in schizophrenia. | Peykov S et al. | β | 2015 | β |
| Identification and functional studies of regulatory variants responsible for the association of <i>NRG3</i> with a delusion phenotype in schizophrenia. | ZeledΓ³n M et al. | β | 2015 | β |
| IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. | Severance EG et al. | β | 2015 | β |
| Immune-related pathways including HLA-DRB1(β)13:02 are associated with panic disorder. | Shimada-Sugimoto M et al. | β | 2015 | β |
| Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. | Khandaker GM et al. | β | 2015 | β |
| Inflammation in schizophrenia: A question of balance. | Leza JC et al. | β | 2015 | β |
| Investigation of fasciculation and elongation protein ΞΆ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia. | Vachev TI et al. | β | 2015 | β |
| Lack of association between microRNA-137 SNP rs1625579 and schizophrenia in a replication study of Han Chinese. | Yuan J et al. | β | 2015 | β |
| Meta-analysis of data from the Psychiatric Genomics Consortium and additional samples supports association of CACNA1C with risk for schizophrenia. | Takahashi S et al. | β | 2015 | β |
| Molecular mechanisms and timing of cortical immune activation in schizophrenia. | Volk DW et al. | β | 2015 | β |
| Multifactoriality in Psychiatric Disorders: A Computational Study of Schizophrenia. | PavΓ£o R et al. | β | 2015 | β |
| Network-Based Analysis of Schizophrenia Genome-Wide Association Data to Detect the Joint Functional Association Signals. | Chang S et al. | β | 2015 | β |
| Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. | Ledonne A et al. | β | 2015 | β |
| Neurodevelopment, GABA system dysfunction, and schizophrenia. | Schmidt MJ et al. | β | 2015 | β |
| Neuronal migration abnormalities and its possible implications for schizophrenia. | Muraki K et al. | β | 2015 | β |
| New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. | Lee SH et al. | β | 2015 | β |
| New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings. | Kotlar AV et al. | β | 2015 | β |
| Organization of TNIK in dendritic spines. | Burette AC et al. | β | 2015 | β |
| Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing. | Duan J | β | 2015 | β |
| Polygenic risk scores in imaging genetics: Usefulness and applications. | Dima D et al. | β | 2015 | β |
| Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility. | Yamada K et al. | β | 2015 | β |
| Refinement of schizophrenia GWAS loci using methylome-wide association data. | Kumar G et al. | β | 2015 | β |
| RNA Sequencing in Schizophrenia. | Li X et al. | β | 2015 | β |
| Schizophrenia genetics: emerging themes for a complex disorder. | Kavanagh DH et al. | β | 2015 | β |
| Schizophrenia or schizophrenias? The challenge of genetic parsing of a complex disorder. | Jablensky A | β | 2015 | β |
| Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. | Gatt JM et al. | β | 2015 | β |
| The immunogenetics of multiple sclerosis: A comprehensive review. | Hollenbach JA et al. | β | 2015 | β |
| The impact of clinical heterogeneity in schizophrenia on genomic analyses. | Liang SG et al. | β | 2015 | β |
| The nervous and the immune systems: conspicuous physiological analogies. | Sotelo J | β | 2015 | β |
| The promise of biological markers for treatment response in first-episode psychosis: a systematic review. | Fond G et al. | β | 2015 | β |
| The search for new biomarkers for cognition in schizophrenia. | PenadΓ©s R et al. | β | 2015 | β |
| Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants. | Duan J et al. | β | 2015 | β |
| Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. | Arnedo J et al. | β | 2015 | β |
| A competitive PCR assay confirms the association of a copy number variation in the VIPR2 gene with schizophrenia in Han Chinese. | Yuan J et al. | β | 2014 | β |
| A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. | Psychosis Endophenotypes International Consortium et al. | β | 2014 | β |
| A hypothesis-driven pathway analysis reveals myelin-related pathways that contribute to the risk of schizophrenia and bipolar disorder. | Yu H et al. | β | 2014 | β |
| A Likelihood-Based Framework for Association Analysis of Allele-Specific Copy Numbers. | Hu YJ et al. | β | 2014 | β |
| A new system identification approach to identify genetic variants in sequencing studies for a binary phenotype. | Kang G et al. | β | 2014 | β |
| A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. | Khandaker GM et al. | β | 2014 | β |
| A population-based study of genetic variation and psychotic experiences in adolescents. | Zammit S et al. | β | 2014 | β |
| A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. | Duan J et al. | β | 2014 | β |
| Association between rs1344706 of ZNF804A and schizophrenia: a meta-analysis. | Zhu M et al. | β | 2014 | β |
| Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients. | Sayeh A et al. | β | 2014 | β |
| Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population. | Wang S et al. | β | 2014 | β |
| Biological insights from 108 schizophrenia-associated genetic loci. | Schizophrenia Working Group of the Psychiatric Genomics Consortium | β | 2014 | β |
| Cannabis abuse and age at onset in schizophrenia patients with large, rare copy number variants. | Martin AK et al. | β | 2014 | β |
| Carbonyl stress in schizophrenia. | Itokawa M et al. | β | 2014 | β |
| Changes in gene expression and methylation in the blood of patients with first-episode psychosis. | Ota VK et al. | β | 2014 | β |
| Coherent somatic mutation in autoimmune disease. | Ross KA | β | 2014 | β |
| Common variant at 16p11.2 conferring risk of psychosis. | Steinberg S et al. | β | 2014 | β |
| Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia. | Chen C et al. | β | 2014 | β |
| Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder. | Houenou J et al. | β | 2014 | β |
| DNA methylation changes in the postmortem dorsolateral prefrontal cortex of patients with schizophrenia. | Numata S et al. | β | 2014 | β |
| DSM-IV "criterion A" schizophrenia symptoms across ethnically different populations: evidence for differing psychotic symptom content or structural organization? | McLean D et al. | β | 2014 | β |
| Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders. | Canellas F et al. | β | 2014 | β |
| Effects of ZNF804A on auditory P300 response in schizophrenia. | O'Donoghue T et al. | β | 2014 | β |
| Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. | Siegel BI et al. | β | 2014 | β |
| Endogenous retrovirus-K and nervous system diseases. | Manghera M et al. | β | 2014 | β |
| Engram formation in psychiatric disorders. | Gebicke-Haerter PJ | β | 2014 | β |
| Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders. | Schadt EE et al. | β | 2014 | β |
| Excess of homozygosity in the major histocompatibility complex in schizophrenia. | Mukherjee S et al. | β | 2014 | β |
| Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia. | Rodriguez-Murillo L et al. | β | 2014 | β |
| Genetically modified mice related to schizophrenia and other psychoses: seeking phenotypic insights into the pathobiology and treatment of negative symptoms. | O'Tuathaigh CM et al. | β | 2014 | β |
| Genetic comorbidities in Parkinson's disease. | Nalls MA et al. | β | 2014 | β |
| Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. | Cardno AG et al. | β | 2014 | β |
| Genetics of obsessive-compulsive disorder and related disorders. | Browne HA et al. | β | 2014 | β |
| Genetics of Psychosis in Alzheimer Disease. | DeMichele-Sweet MA et al. | β | 2014 | β |
| Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. | BΓΈrglum AD et al. | β | 2014 | β |
| Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon. | Lin M et al. | β | 2014 | β |
| HLA associations in schizophrenia: are we re-discovering the wheel? | Kodavali CV et al. | β | 2014 | β |
| Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish national registers. | Nielsen PR et al. | β | 2014 | β |
| Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia. | Juraeva D et al. | β | 2014 | β |
| Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants. | Wang S et al. | β | 2014 | β |
| Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia. | Forstner AJ et al. | β | 2014 | β |
| Large-scale genomics unveils the genetic architecture of psychiatric disorders. | Gratten J et al. | β | 2014 | β |
| Major histocompatibility complex I in brain development and schizophrenia. | McAllister AK | β | 2014 | β |
| Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. | Pearlman DM et al. | β | 2014 | β |
| MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. | Shi S et al. | β | 2014 | β |
| Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). | Lencz T et al. | β | 2014 | β |
| Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. | Schulze TG et al. | β | 2014 | β |
| Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. | Mei L et al. | β | 2014 | β |
| Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. | Cristino AS et al. | β | 2014 | β |
| No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophrenia. | Tosato S et al. | β | 2014 | β |
| No evidence that runs of homozygosity are associated with schizophrenia in an Irish genome-wide association dataset. | Heron EA et al. | β | 2014 | β |
| Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia. | Wang C et al. | β | 2014 | β |
| Novel treatment strategies for schizophrenia from improved understanding of genetic risk. | Morris BJ et al. | β | 2014 | β |
| Pharmacogenetics of second-generation antipsychotics. | Brennan MD | β | 2014 | β |
| Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. | GarcΓa-Bueno B et al. | β | 2014 | β |
| Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia. | Wang KS et al. | β | 2014 | β |
| Protein-interaction-network-based analysis for genome-wide association analysis of schizophrenia in Han Chinese population. | Yu H et al. | β | 2014 | β |
| Psychiatrists' views of the genetic bases of mental disorders and behavioral traits and their use of genetic tests. | Klitzman R et al. | β | 2014 | β |
| Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. | Mulle JG et al. | β | 2014 | β |
| Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis. | Saito T et al. | β | 2014 | β |
| Research review: Polygenic methods and their application to psychiatric traits. | Wray NR et al. | β | 2014 | β |
| Risk genes for schizophrenia: translational opportunities for drug discovery. | Winchester CL et al. | β | 2014 | β |
| Scoring the collective effects of SNPs: association of minor alleles with complex traits in model organisms. | Yuan D et al. | β | 2014 | β |
| Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. | Crabtree GW et al. | β | 2014 | β |
| The future of neuroepigenetics in the human brain. | Mitchell A et al. | β | 2014 | β |
| The genome in three dimensions: a new frontier in human brain research. | Mitchell AC et al. | β | 2014 | β |
| Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia. | Hagihara H et al. | β | 2014 | β |
| Where now for schizophrenia research? | Nutt DJ et al. | β | 2014 | β |
| A comprehensive family-based replication study of schizophrenia genes. | Aberg KA et al. | β | 2013 | β |
| Additive genetic variation in schizophrenia risk is shared by populations of African and European descent. | de Candia TR et al. | β | 2013 | β |
| A genetic association study between common variants in the ABCA13 gene and schizophrenia in a Han Chinese population. | Ma J et al. | β | 2013 | β |
| A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder. | Fernandes CP et al. | β | 2013 | β |
| Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening. | Aleksic B et al. | β | 2013 | β |
| Anti-inflammatory treatment in schizophrenia. | MΓΌller N et al. | β | 2013 | β |
| A population-based association study of 2q32.3 and 8q21.3 loci with schizophrenia in Han Chinese. | Guan F et al. | β | 2013 | β |
| A population-specific uncommon variant in GRIN3A associated with schizophrenia. | Takata A et al. | β | 2013 | β |
| A review of anti-inflammatory agents for symptoms of schizophrenia. | Keller WR et al. | β | 2013 | β |
| Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis. | Zhao Z et al. | β | 2013 | β |
| Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample. | Kukshal P et al. | β | 2013 | β |
| A systematic, quantitative review of blood autoantibodies in schizophrenia. | Ezeoke A et al. | β | 2013 | β |
| BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies. | Xu C et al. | β | 2013 | β |
| Child development and molecular genetics: 14 years later. | Plomin R | β | 2013 | β |
| Cortical surface area correlates with STON2 gene Ser307Pro polymorphism in first-episode treatment-naΓ―ve patients with schizophrenia. | Xiang B et al. | β | 2013 | β |
| Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis. | Tezuka T et al. | β | 2013 | β |
| Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. | Takao K et al. | β | 2013 | β |
| Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. | Agim ZS et al. | β | 2013 | β |
| DNA methylation signatures of peripheral leukocytes in schizophrenia. | Kinoshita M et al. | β | 2013 | β |
| Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort. | Kukshal P et al. | β | 2013 | β |
| ENCODE and a new landscape for psychiatric genetics. | Nair A et al. | β | 2013 | β |
| Epigenetics in the human brain. | Houston I et al. | β | 2013 | β |
| Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future. | Dempster E et al. | β | 2013 | β |
| Evaluating rare variants in complex disorders using next-generation sequencing. | Ezewudo M et al. | β | 2013 | β |
| Evidence for a dysregulated immune system in the etiology of psychiatric disorders. | Gibney SM et al. | β | 2013 | β |
| Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis. | Liu Y et al. | β | 2013 | β |
| Expression of immune genes on chromosome 6p21.3-22.1 in schizophrenia. | Sinkus ML et al. | β | 2013 | β |
| From gene to brain to behavior: schizophrenia-associated variation in AMBRA1 alters impulsivity-related traits. | Heinrich A et al. | β | 2013 | β |
| GABBR1 has a HERV-W LTR in its regulatory region--a possible implication for schizophrenia. | Hegyi H | β | 2013 | β |
| Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. | Gardiner EJ et al. | β | 2013 | β |
| Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication. | Kumarasinghe N et al. | β | 2013 | β |
| Genetic association analysis of ITGB3 polymorphisms with age at onset of schizophrenia. | Wang KS et al. | β | 2013 | β |
| Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia. | Schwab SG et al. | β | 2013 | β |
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia. | Ripke S et al. | β | 2013 | β |
| Genome-wide association study of schizophrenia using microsatellite markers in the Japanese population. | Shibata H et al. | β | 2013 | β |
| Genome-wide linkage analysis of cardiovascular disease biomarkers in a large, multigenerational family. | Nolan D et al. | β | 2013 | β |
| Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. | Hamshere ML et al. | β | 2013 | β |
| Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. | Green MJ et al. | β | 2013 | β |
| Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health's Collaborative Center for Genomic Studies. | Odgerel Z et al. | β | 2013 | β |
| Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. | Cole AR | β | 2013 | β |
| Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface. | Leboyer M et al. | β | 2013 | β |
| Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. | Hagihara H et al. | β | 2013 | β |
| Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. | Fineberg AM et al. | β | 2013 | β |
| Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. | Perez-Andreu V et al. | β | 2013 | β |
| Lack of association between MPC2 variants and schizophrenia in a replication study of Han Chinese. | Jin C et al. | β | 2013 | β |
| Lack of genetic association of the HLA-DQA1(β)0501 variant with schizophrenia in a Chinese population. | Guan S et al. | β | 2013 | β |
| Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population. | Li M et al. | β | 2013 | β |
| Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects. | Miller BJ et al. | β | 2013 | β |
| Meta-regression of gene-environment interaction in genome-wide association studies. | Xu X et al. | β | 2013 | β |
| MHC class I immune proteins are critical for hippocampus-dependent memory and gate NMDAR-dependent hippocampal long-term depression. | Nelson PA et al. | β | 2013 | β |
| MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease. | Elmer BM et al. | β | 2013 | β |
| Modulation of behavior by scaffolding proteins of the post-synaptic density. | Gao C et al. | β | 2013 | β |
| [Molecular basis of brain disruption in neuropsychological diseases]. | Yamada K et al. | β | 2013 | β |
| Mosaic copy number variation in schizophrenia. | Ruderfer DM et al. | β | 2013 | β |
| Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response. | Koike S et al. | β | 2013 | β |
| Neonatal levels of acute phase proteins and later risk of non-affective psychosis. | Gardner RM et al. | β | 2013 | β |
| Neuroimaging as a potential biomarker to optimize psychiatric research and treatment. | Walton E et al. | β | 2013 | β |
| Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. | Donohoe G et al. | β | 2013 | β |
| Nogo and Nogo receptor: relevance to schizophrenia? | Willi R et al. | β | 2013 | β |
| Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. | Xu H et al. | β | 2013 | β |
| Paradoxical downregulation of HLA-A expression by IFNΞ³ associated with schizophrenia and noncoding genes. | Gu S et al. | β | 2013 | β |
| Personalized medicine in psychiatry: problems and promises. | Ozomaro U et al. | β | 2013 | β |
| PGMRA: a web server for (phenotype x genotype) many-to-many relation analysis in GWAS. | Arnedo J et al. | β | 2013 | β |
| Potential metabolite markers of schizophrenia. | Yang J et al. | β | 2013 | β |
| Power and predictive accuracy of polygenic risk scores. | Dudbridge F | β | 2013 | β |
| Prefrontal cortical dysfunction after overexpression of histone deacetylase 1. | Jakovcevski M et al. | β | 2013 | β |
| Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies. | Miller BJ et al. | β | 2013 | β |
| Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. | Khandaker GM et al. | β | 2013 | β |
| Regulation of spine formation by ErbB4 in PV-positive interneurons. | Yin DM et al. | β | 2013 | β |
| Replication of association between schizophrenia and chromosome 6p21-6p22.1 polymorphisms in Chinese Han population. | Zhang Y et al. | β | 2013 | β |
| Replication study confirms link between TSPAN18 mutation and schizophrenia in Han Chinese. | Yuan J et al. | β | 2013 | β |
| Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. | Yin DM et al. | β | 2013 | β |
| Schizophrenia as a human leukocyte antigen-associated disease revisited. | McGuffin P et al. | β | 2013 | β |
| Search for schizophrenia susceptibility variants at the HLA-DRB1 locus among a British population. | Halley L et al. | β | 2013 | β |
| Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. | Goldstein JM et al. | β | 2013 | β |
| SLC17: a functionally diverse family of organic anion transporters. | Reimer RJ | β | 2013 | β |
| The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants. | Mowry BJ et al. | β | 2013 | β |
| The genomic psychiatry cohort: partners in discovery. | Pato MT et al. | β | 2013 | β |
| The genomics of schizophrenia: update and implications. | Giusti-RodrΓguez P et al. | β | 2013 | β |
| The implications of genomics on the nursing care of adults with neuropsychiatric conditions. | Schutte DL et al. | β | 2013 | β |
| The regulation of gene expression involved in TGF-Ξ² signaling by ZNF804A, a risk gene for schizophrenia. | Umeda-Yano S et al. | β | 2013 | β |
| Transcriptome study of differential expression in schizophrenia. | Sanders AR et al. | β | 2013 | β |
| Two gene co-expression modules differentiate psychotics and controls. | Chen C et al. | β | 2013 | β |
| Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications. | Debnath M et al. | β | 2013 | β |
| Viruses and neurodegeneration. | Zhou L et al. | β | 2013 | β |
| A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. | Jia P et al. | β | 2012 | β |
| A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. | de Jong S et al. | β | 2012 | β |
| A genome-wide association study of attempted suicide. | Willour VL et al. | β | 2012 | β |
| A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. | Kaminsky Z et al. | β | 2012 | β |
| An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. | Schmidt-Kastner R et al. | β | 2012 | β |
| Annual research review: impact of advances in genetics in understanding developmental psychopathology. | Addington AM et al. | β | 2012 | β |
| A polymerase chain reaction-restriction fragment length polymorphism method for screening ZNF804A gene polymorphism (rs1344706) in patients with schizophrenia: a significant association. | Sazci A et al. | β | 2012 | β |
| ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. | Xu H et al. | β | 2012 | β |
| Association analysis of ZNF804A (zinc finger protein 804A) rs1344706 with therapeutic response to atypical antipsychotics in first-episode Chinese patients with schizophrenia. | Zhang J et al. | β | 2012 | β |
| Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. | Rietschel M et al. | β | 2012 | β |
| Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. | MΓΌhleisen TW et al. | β | 2012 | β |
| Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies. | Hirata Y et al. | β | 2012 | β |
| Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. | Carrera N et al. | β | 2012 | β |
| Cancer in parents of persons with schizophrenia: is there a genetic protection? | Gal G et al. | β | 2012 | β |
| Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. | Costain G et al. | β | 2012 | β |
| Collection of clinical and epidemiological data for genetic linkage and association studies. | Farrer L et al. | β | 2012 | β |
| Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients. | Koide T et al. | β | 2012 | β |
| Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. | Severance EG et al. | β | 2012 | β |
| Contributions of the D-serine pathway to schizophrenia. | Labrie V et al. | β | 2012 | β |
| Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. | Ayalew M et al. | β | 2012 | β |
| Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia. | Winchester CL et al. | β | 2012 | β |
| Copy number variation in the cattle genome. | Liu GE et al. | β | 2012 | β |
| Copy number variation of individual cattle genomes using next-generation sequencing. | Bickhart DM et al. | β | 2012 | β |
| DISC1 as a therapeutic target for mental illnesses. | Hikida T et al. | β | 2012 | β |
| DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders. | Kamiya A et al. | β | 2012 | β |
| Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. | Gilman SR et al. | β | 2012 | β |
| DNA methylation in schizophrenia: progress and challenges of epigenetic studies. | Nishioka M et al. | β | 2012 | β |
| DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. | Alkelai A et al. | β | 2012 | β |
| Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. | Brown AS | β | 2012 | β |
| Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. | Lee SH et al. | β | 2012 | β |
| Evaluation of factors affecting continuous performance test identical pairs version score of schizophrenic patients in a Japanese clinical sample. | Koide T et al. | β | 2012 | β |
| Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. | Bamne M et al. | β | 2012 | β |
| Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. | Visscher PM et al. | β | 2012 | β |
| Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. | Need AC et al. | β | 2012 | β |
| Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. | de Jong S et al. | β | 2012 | β |
| Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia. | Kumarasinghe N et al. | β | 2012 | β |
| Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. | Lips ES et al. | β | 2012 | β |
| Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia. | Uezato A et al. | β | 2012 | β |
| Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706. | Zhang R et al. | β | 2012 | β |
| Gastrointestinal inflammation and associated immune activation in schizophrenia. | Severance EG et al. | β | 2012 | β |
| Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders. | Ersland KM et al. | β | 2012 | β |
| Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls. | Maschietto M et al. | β | 2012 | β |
| Genetic and cognitive windows into circuit mechanisms of psychiatric disease. | Arguello PA et al. | β | 2012 | β |
| Genetic architectures of psychiatric disorders: the emerging picture and its implications. | Sullivan PF et al. | β | 2012 | β |
| Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families. | Yokley JL et al. | β | 2012 | β |
| Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics. | Ferentinos P et al. | β | 2012 | β |
| Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia. | Zhang R et al. | β | 2012 | β |
| Genetic overlap of schizophrenia and bipolar disorder in a high-density linkage survey in the Portuguese Island population. | Fanous AH et al. | β | 2012 | β |
| Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population. | Huo R et al. | β | 2012 | β |
| Genetics of schizophrenia from a clinicial perspective. | Kukshal P et al. | β | 2012 | β |
| Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? | Lee KW et al. | β | 2012 | β |
| Genome-wide association studies in schizophrenia, and potential etiological and functional implications of their results. | HosΓ‘k L et al. | β | 2012 | β |
| Genome-wide association studies of schizophrenia: does bigger lead to better results? | Bergen SE et al. | β | 2012 | β |
| Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. | Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2 | β | 2012 | β |
| Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. | Bergen SE et al. | β | 2012 | β |
| Genome-wide association study of Alzheimer's disease with psychotic symptoms. | Hollingworth P et al. | β | 2012 | β |
| Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. | Fanous AH et al. | β | 2012 | β |
| Genome-wide association study of multiplex schizophrenia pedigrees. | Levinson DF et al. | β | 2012 | β |
| Genome-wide association study of treatment refractory schizophrenia in Han Chinese. | Liou YJ et al. | β | 2012 | β |
| HLA and SNP haplotype mapping in the Japanese population. | Kitajima H et al. | β | 2012 | β |
| Human genetics of schizophrenia. | Claes S et al. | β | 2012 | β |
| Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. | Collins AL et al. | β | 2012 | β |
| Immune system gene dysregulation in autism and schizophrenia. | Michel M et al. | β | 2012 | β |
| Inflammation in schizophrenia. | MΓΌller N et al. | β | 2012 | β |
| Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. | Gupta A et al. | β | 2012 | β |
| Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia. | Sun J et al. | β | 2012 | β |
| Investigation of allelic heterogeneity of the CCK-A receptor gene in paranoid schizophrenia. | Zheng C et al. | β | 2012 | β |
| Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition. | Pelov I et al. | β | 2012 | β |
| Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. | Tosato S et al. | β | 2012 | β |
| Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder. | Graw SL et al. | β | 2012 | β |
| Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia. | Li Y et al. | β | 2012 | β |
| Less cognitive and neurological deficits in schizophrenia patients carrying risk variant in ZNF804A. | Van Den Bossche MJ et al. | β | 2012 | β |
| MAGI1 copy number variation in bipolar affective disorder and schizophrenia. | Karlsson R et al. | β | 2012 | β |
| Major histocompatibility complex class I proteins in brain development and plasticity. | Elmer BM et al. | β | 2012 | β |
| MBL and MASP-2 concentrations in serum and MBL2 promoter polymorphisms are associated to schizophrenia. | Foldager L et al. | β | 2012 | β |
| Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility. | Li M et al. | β | 2012 | β |
| Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder. | Perron H et al. | β | 2012 | β |
| Multivariate phenotype association analysis by marker-set kernel machine regression. | Maity A et al. | β | 2012 | β |
| Network-assisted investigation of antipsychotic drugs and their targets. | Sun J et al. | β | 2012 | β |
| Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. | Jia P et al. | β | 2012 | β |
| Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110Ξ΄ inhibition as a potential therapeutic strategy. | Law AJ et al. | β | 2012 | β |
| No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia. | Kitazawa M et al. | β | 2012 | β |
| Pathway based analysis of genotypes in relation to alcohol dependence. | Reimers MA et al. | β | 2012 | β |
| PKNOX2 is associated with formal thought disorder in schizophrenia: a meta-analysis of two genome-wide association studies. | Wang KS et al. | β | 2012 | β |
| Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. | Chen SJ et al. | β | 2012 | β |
| Recent genomic advances in schizophrenia. | Doherty JL et al. | β | 2012 | β |
| Reconsidering the association between the major histocompatibility complex and bipolar disorder. | Figueiredo TC et al. | β | 2012 | β |
| RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia. | Xu J et al. | β | 2012 | β |
| Schizophrenia genes: on the matter of their convergence. | Rujescu D | β | 2012 | β |
| Schizophrenia genetics: progress, at last. | Mulle JG | β | 2012 | β |
| Schizophrenia shows a unique metabolomics signature in plasma. | He Y et al. | β | 2012 | β |
| Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. | Richards AL et al. | β | 2012 | β |
| Searching joint association signals in CATIE schizophrenia genome-wide association studies through a refined integrative network approach. | Jia P et al. | β | 2012 | β |
| Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples. | Gladwin TE et al. | β | 2012 | β |
| Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample. | McLean D et al. | β | 2012 | β |
| Spectrum of autoantibodies in Tunisian psychiatric inpatients. | Sidhom O et al. | β | 2012 | β |
| Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. | Andreasen NC et al. | β | 2012 | β |
| Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study. | Liu Q et al. | β | 2012 | β |
| The future of fMRI and genetics research. | Meyer-Lindenberg A | β | 2012 | β |
| The genetic architecture of schizophrenia: new mutations and emerging paradigms. | Rodriguez-Murillo L et al. | β | 2012 | β |
| The hunt for gene effects pertinent to behavioral traits and psychiatric disorders: from mouse to human. | Wahlsten D | β | 2012 | β |
| The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors. | Luo XJ et al. | β | 2012 | β |
| The major histocompatibility complex and autism spectrum disorder. | Needleman LA et al. | β | 2012 | β |
| The role of immune dysfunction in the pathophysiology of autism. | Onore C et al. | β | 2012 | β |
| TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function. | Coba MP et al. | β | 2012 | β |
| What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. | Panagiotou OA et al. | β | 2012 | β |
| ZNF804A and schizophrenia susceptibility in Asian populations. | Li M et al. | β | 2012 | β |
| ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. | Girgenti MJ et al. | β | 2012 | β |
| Ablation of Mrds1/Ofcc1 induces hyper-Ξ³-glutamyl transpeptidasemia without abnormal head development and schizophrenia-relevant behaviors in mice. | Ohnishi T et al. | β | 2011 | β |
| A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population. | Banno M et al. | β | 2011 | β |
| A comprehensive network and pathway analysis of candidate genes in major depressive disorder. | Jia P et al. | β | 2011 | β |
| [A critical appraisal of genome-wide association studies of psychiatric disorders: unmet expectations]. | Hebebrand J | β | 2011 | β |
| ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. | Chen J et al. | β | 2011 | β |
| ADAMTSL3 as a candidate gene for schizophrenia: gene sequencing and ultra-high density association analysis by imputation. | Dow DJ et al. | β | 2011 | β |
| Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia. | Kano S et al. | β | 2011 | β |
| A map of copy number variations in Chinese populations. | Lou H et al. | β | 2011 | β |
| An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. | Kaminsky EB et al. | β | 2011 | β |
| Animal model for schizophrenia that reflects gene-environment interactions. | Nagai T et al. | β | 2011 | β |
| An improved kinetic model for the acetone-butanol-ethanol pathway of Clostridium acetobutylicum and model-based perturbation analysis. | Li RD et al. | β | 2011 | β |
| Anti-inflammatory signaling in schizophrenia. | Meyer U | β | 2011 | β |
| A population genetic approach to mapping neurological disorder genes using deep resequencing. | Myers RA et al. | β | 2011 | β |
| Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. | Sun J et al. | β | 2011 | β |
| Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis-acting regulation of mRNA expression in adult human brain. | Williams HJ et al. | β | 2011 | β |
| Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia. | Bakken TE et al. | β | 2011 | β |
| Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk. | Demontis D et al. | β | 2011 | β |
| Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence. | Jackson KJ et al. | β | 2011 | β |
| Challenges of introducing new biomarker products for neuropsychiatric disorders into the market. | Bahn S et al. | β | 2011 | β |
| Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs. | Moons T et al. | β | 2011 | β |
| Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. | Frank RA et al. | β | 2011 | β |
| Common sequence variants in the major histocompatibility complex region associate with cerebral ventricular size in schizophrenia. | Agartz I et al. | β | 2011 | β |
| Common variants at VRK2 and TCF4 conferring risk of schizophrenia. | Steinberg S et al. | β | 2011 | β |
| Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. | Shi Y et al. | β | 2011 | β |
| Comparative immunogenetics of autism and schizophrenia. | Crespi BJ et al. | β | 2011 | β |
| Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia. | Tang B et al. | β | 2011 | β |
| Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness. | Bigdeli TB et al. | β | 2011 | β |
| Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. | Brennand KJ et al. | β | 2011 | β |
| Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients. | Molina V et al. | β | 2011 | β |
| Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. | Levinson DF et al. | β | 2011 | β |
| Decanalization, brain development and risk of schizophrenia. | McGrath JJ et al. | β | 2011 | β |
| Detecting autozygosity through runs of homozygosity: a comparison of three autozygosity detection algorithms. | Howrigan DP et al. | β | 2011 | β |
| Developments in schizophrenia genetics: from linkage to microchips, deletions and duplications. | Haraldsson HM et al. | β | 2011 | β |
| Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. | Papiol S et al. | β | 2011 | β |
| Do common variants play a role in risk for autism? Evidence and theoretical musings. | Devlin B et al. | β | 2011 | β |
| Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. | Vacic V et al. | β | 2011 | β |
| Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade. | Ghiani CA et al. | β | 2011 | β |
| Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment. | Nagai T et al. | β | 2011 | β |
| Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. | So HC et al. | β | 2011 | β |
| Evidence of sex-modulated association of ZNF804A with schizophrenia. | Zhang F et al. | β | 2011 | β |
| Exonic DNA sequencing of ERBB4 in bipolar disorder. | Goes FS et al. | β | 2011 | β |
| Expanding the range of ZNF804A variants conferring risk of psychosis. | Steinberg S et al. | β | 2011 | β |
| Exposure to prenatal infection and risk of schizophrenia. | Brown AS | β | 2011 | β |
| Face emotion recognition is related to individual differences in psychosis-proneness. | Germine LT et al. | β | 2011 | β |
| Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. | Williams HJ et al. | β | 2011 | β |
| Following the genes: a framework for animal modeling of psychiatric disorders. | Mitchell KJ et al. | β | 2011 | β |
| Genetic association studies of antioxidant pathway genes and schizophrenia. | Chowdari KV et al. | β | 2011 | β |
| Genetic contributions to behavioural diversity at the gene-environment interface. | Bendesky A et al. | β | 2011 | β |
| Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. | Dumitrescu L et al. | β | 2011 | β |
| Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes. | Mozhui K et al. | β | 2011 | β |
| Genetic risk sum score comprised of common polygenic variation is associated with body mass index. | Peterson RE et al. | β | 2011 | β |
| Genetics of schizophrenia: new findings and challenges. | Gejman PV et al. | β | 2011 | β |
| Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. | Hochstenbach R et al. | β | 2011 | β |
| Genome-wide association analysis of age at onset in schizophrenia in a European-American sample. | Wang KS et al. | β | 2011 | β |
| Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample. | Kendler KS et al. | β | 2011 | β |
| Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. | Yue WH et al. | β | 2011 | β |
| Genome-wide association study identifies five new schizophrenia loci. | Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium | β | 2011 | β |
| Genome-wide association study of schizophrenia in a Japanese population. | Ikeda M et al. | β | 2011 | β |
| Genome-wide association study of schizophrenia in Japanese population. | Yamada K et al. | β | 2011 | β |
| Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. | McClay JL et al. | β | 2011 | β |
| GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. | Chen X et al. | β | 2011 | β |
| Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. | Costas J et al. | β | 2011 | β |
| Hierarchical temporal processing deficit model of reality distortion and psychoses. | Krishnan RR et al. | β | 2011 | β |
| HLA, immunogenetics, pharmacogenetics and personalized medicine. | Charron D | β | 2011 | β |
| Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. | Alkelai A et al. | β | 2011 | β |
| Impact of antipsychotics on cytokine production in-vitro. | Himmerich H et al. | β | 2011 | β |
| Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene. | Yasuda Y et al. | β | 2011 | β |
| Increased exonic de novo mutation rate in individuals with schizophrenia. | Girard SL et al. | β | 2011 | β |
| Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. | Meyer U et al. | β | 2011 | β |
| Interaction between FEZ1 and DISC1 in regulation of neuronal development and risk for schizophrenia. | Kang E et al. | β | 2011 | β |
| Intron 12 in NTRK3 is associated with bipolar disorder. | Athanasiu L et al. | β | 2011 | β |
| Is the conserved mammalian region of ZNF804A locus associated with schizophrenia? A population-based genetics analysis. | Zhang R et al. | β | 2011 | β |
| Linkage and association on 8p21.2-p21.1 in schizophrenia. | Fallin MD et al. | β | 2011 | β |
| Linking neurodevelopmental and synaptic theories of mental illness through DISC1. | Brandon NJ et al. | β | 2011 | β |
| Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: a combined analysis of independent samples. | Saetre P et al. | β | 2011 | β |
| Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. | Williams HJ et al. | β | 2011 | β |
| Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. | Carroll LS et al. | β | 2011 | β |
| Neurogenetics and pharmacology of learning, motivation, and cognition. | Frank MJ et al. | β | 2011 | β |
| No association observed between schizophrenia and non-HLA coeliac disease genes: integration with the initial MYO9B association with coeliac disease. | Law MH et al. | β | 2011 | β |
| Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. | Shyn SI et al. | β | 2011 | β |
| Optimal methods for meta-analysis of genome-wide association studies. | Zhou B et al. | β | 2011 | β |
| Pathway-based analysis of GWAS datasets: effective but caution required. | Jia P et al. | β | 2011 | β |
| Possible association between interleukin-1Ξ² gene and schizophrenia in a Japanese population. | Sasayama D et al. | β | 2011 | β |
| Progress in defining the biological causes of schizophrenia. | Pickard B | β | 2011 | β |
| Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. | Tarabeux J et al. | β | 2011 | β |
| Rethinking the genetic architecture of schizophrenia. | Mitchell KJ et al. | β | 2011 | β |
| Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now? | MΓΌller N et al. | β | 2011 | β |
| Schizophrenia genetics: where next? | Kim Y et al. | β | 2011 | β |
| Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo. | Allen JA et al. | β | 2011 | β |
| Schizophrenia: treatment targets beyond monoamine systems. | Ibrahim HM et al. | β | 2011 | β |
| Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis. | Kishi T et al. | β | 2011 | β |
| Sex-specific rates of transmission of psychosis in the New England high-risk family study. | Goldstein JM et al. | β | 2011 | β |
| Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. | Glatt SJ et al. | β | 2011 | β |
| Six Degrees of Epistasis: Statistical Network Models for GWAS. | McKinney BA et al. | β | 2011 | β |
| The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | HΓ₯vik B et al. | β | 2011 | β |
| The environment and susceptibility to schizophrenia. | Brown AS | β | 2011 | β |
| The genetics of neurodevelopmental disease. | Mitchell KJ | β | 2011 | β |
| The MDGA1 gene confers risk to schizophrenia and bipolar disorder. | Li J et al. | β | 2011 | β |
| The MHC, disease and selection. | Trowsdale J | β | 2011 | β |
| The molecular genetics of autism spectrum disorders: genomic mechanisms, neuroimmunopathology, and clinical implications. | Guerra DJ | β | 2011 | β |
| The presynaptic component of the serotonergic system is required for clozapine's efficacy. | Yadav PN et al. | β | 2011 | β |
| The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. | Wang Q et al. | β | 2011 | β |
| The shock of the new: progress in schizophrenia genomics. | Moore S et al. | β | 2011 | β |
| Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. | Barnes MR et al. | β | 2011 | β |
| Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. | Kas MJ et al. | β | 2011 | β |
| Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. | Chen J et al. | β | 2011 | β |
| Two patients walk into a clinic...a genomics perspective on the future of schizophrenia. | Corvin AP | β | 2011 | β |
| Variants of the RELA gene are associated with schizophrenia and their startle responses. | Hashimoto R et al. | β | 2011 | β |
| What kinds of things are psychiatric disorders? | Kendler KS et al. | β | 2011 | β |
| Where are the missing pieces of the schizophrenia genetics puzzle? | Girard SL et al. | β | 2011 | β |
| AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | Bendor J et al. | β | 2010 | β |
| A genome-wide association study of Cloninger's temperament scales: implications for the evolutionary genetics of personality. | Verweij KJ et al. | β | 2010 | β |
| A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. | Wang KS et al. | β | 2010 | β |
| A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. | Ingason A et al. | β | 2010 | β |
| Analysis of copy number variations among diverse cattle breeds. | Liu GE et al. | β | 2010 | β |
| An integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes. | Chu TT et al. | β | 2010 | β |
| Autoimmune diseases, bipolar disorder, and non-affective psychosis. | Eaton WW et al. | β | 2010 | β |
| Beyond the first episode: candidate factors for a risk prediction model of schizophrenia. | Murphy BP | β | 2010 | β |
| Case-control genome-wide association study of attention-deficit/hyperactivity disorder. | Neale BM et al. | β | 2010 | β |
| Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. | MΓΌller N et al. | β | 2010 | β |
| Child and adolescent psychiatric genetics. | Hebebrand J et al. | β | 2010 | β |
| Cognition in mouse models of schizophrenia susceptibility genes. | Arguello PA et al. | β | 2010 | β |
| Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. | BrzΓ³zka MM et al. | β | 2010 | β |
| Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese. | Zhang W et al. | β | 2010 | β |
| Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. | Jia P et al. | β | 2010 | β |
| Common variants in major histocompatibility complex region and TCF4 gene are significantly associated with schizophrenia in Han Chinese. | Li T et al. | β | 2010 | β |
| Comparison of multimarker logistic regression models, with application to a genomewide scan of schizophrenia. | Wason JM et al. | β | 2010 | β |
| Correspondence to Sand et Al. "Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia". | Lill CM et al. | β | 2010 | β |
| Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. | Watanabe Y et al. | β | 2010 | β |
| Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. | Moreno-De-Luca D et al. | β | 2010 | β |
| Developmental function of HMGN proteins. | Furusawa T et al. | β | 2010 | β |
| Development of animal models for schizophrenia. | Arguello PA et al. | β | 2010 | β |
| Epidemiology-driven neurodevelopmental animal models of schizophrenia. | Meyer U et al. | β | 2010 | β |
| Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: a three-stage case-control association study. | Amagane H et al. | β | 2010 | β |
| Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence. | Torri F et al. | β | 2010 | β |
| Fine-mapping reveals novel alternative splicing of the dopamine transporter. | Talkowski ME et al. | β | 2010 | β |
| From maps to mechanisms through neuroimaging of schizophrenia. | Meyer-Lindenberg A | β | 2010 | β |
| Further investigation of the association between rs7341475 and rs17746501 and schizophrenia. | Ben-David E et al. | β | 2010 | β |
| Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency. | Cheli VT et al. | β | 2010 | β |
| Genetics in schizophrenia: where are we and what next? | Tiwari AK et al. | β | 2010 | β |
| Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. | Athanasiu L et al. | β | 2010 | β |
| Genome-wide approaches to schizophrenia. | Duan J et al. | β | 2010 | β |
| Genomewide association studies and assessment of the risk of disease. | Manolio TA | β | 2010 | β |
| Genome-wide association studies: a powerful tool for neurogenomics. | Cowperthwaite MC et al. | β | 2010 | β |
| Genome-wide association studies: a primer. | Corvin A et al. | β | 2010 | β |
| Genomic copy number variation in disorders of cognitive development. | Morrow EM | β | 2010 | β |
| Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. | Chen SK et al. | β | 2010 | β |
| Identifying gene regulatory networks in schizophrenia. | Potkin SG et al. | β | 2010 | β |
| Imaging genetics of schizophrenia. | Meyer-Lindenberg A | β | 2010 | β |
| Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. | Willeit M et al. | β | 2010 | β |
| Immune activation by casein dietary antigens in bipolar disorder. | Severance EG et al. | β | 2010 | β |
| Immune System and Schizophrenia. | MΓΌller N et al. | β | 2010 | β |
| Intermediate or brainless phenotypes for psychiatric research? | Meyer-Lindenberg A | β | 2010 | β |
| Microdeletions of 3q29 confer high risk for schizophrenia. | Mulle JG et al. | β | 2010 | β |
| MicroRNA dysregulation in psychiatric disease. | Miller BH et al. | β | 2010 | β |
| MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. | Kim AH et al. | β | 2010 | β |
| MINK and TNIK differentially act on Rap2-mediated signal transduction to regulate neuronal structure and AMPA receptor function. | Hussain NK et al. | β | 2010 | β |
| Narrowing the boundaries of the genetic architecture of schizophrenia. | Wray NR et al. | β | 2010 | β |
| Nature and nurture in neuropsychiatric genetics: where do we stand? | Dick DM et al. | β | 2010 | β |
| Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention? | Reinvang I et al. | β | 2010 | β |
| Neuronal cell adhesion genes: Key players in risk for schizophrenia, bipolar disorder and other neurodevelopmental brain disorders? | Corvin AP | β | 2010 | β |
| New findings in the genetics of major psychoses. | NΓΆthen MM et al. | β | 2010 | β |
| New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? | Nieratschker V et al. | β | 2010 | β |
| No evidence that rare coding variants in ZNF804A confer risk of schizophrenia. | Dwyer S et al. | β | 2010 | β |
| Novel immune response to gluten in individuals with schizophrenia. | Samaroo D et al. | β | 2010 | β |
| Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. | Garay PA et al. | β | 2010 | β |
| Penetrance for copy number variants associated with schizophrenia. | Vassos E et al. | β | 2010 | β |
| Predictive and diagnostic genetic testing in psychiatry. | Mitchell PB et al. | β | 2010 | β |
| Predictive, preventive, personalized and participatory medicine: back to the future. | Auffray C et al. | β | 2010 | β |
| Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. | Brown AS et al. | β | 2010 | β |
| [PREs, sequences conveying epigenetic memory, are conserved during evolution]. | Poisot E et al. | β | 2010 | β |
| Replicated genetic evidence supports a role for HOMER2 in schizophrenia. | Gilks WP et al. | β | 2010 | β |
| REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. | Van Winkel R et al. | β | 2010 | β |
| Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. | Sun J et al. | β | 2010 | β |
| Schizophrenic: forever young? | Baldi BF et al. | β | 2010 | β |
| Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009. | Amstadter AB et al. | β | 2010 | β |
| SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. | Loe-Mie Y et al. | β | 2010 | β |
| SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders. | Steen NE et al. | β | 2010 | β |
| Strategies for the study of neuropsychiatric disorders using endophenotypes in developing countries: a potential databank from china. | Chan RC et al. | β | 2010 | β |
| Strong synaptic transmission impact by copy number variations in schizophrenia. | Glessner JT et al. | β | 2010 | β |
| Substance use disorders: realizing the promise of pharmacogenomics and personalized medicine. | Hutchison KE | β | 2010 | β |
| Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis. | Lu CL et al. | β | 2010 | β |
| Support of association between BRD1 and both schizophrenia and bipolar affective disorder. | Nyegaard M et al. | β | 2010 | β |
| TCF4, schizophrenia, and Pitt-Hopkins Syndrome. | Blake DJ et al. | β | 2010 | β |
| The diagnosis of mental disorders: the problem of reification. | Hyman SE | β | 2010 | β |
| [The genetics of schizophrenia: back to the clinic?]. | Krebs MO et al. | β | 2010 | β |
| The hippocampal formation in schizophrenia. | Tamminga CA et al. | β | 2010 | β |
| The Internet-based MGS2 control sample: self report of mental illness. | Sanders AR et al. | β | 2010 | β |
| The neurobiology of schizophrenia: new leads and avenues for treatment. | Bray NJ et al. | β | 2010 | β |
| The potential role of major histocompatibility complex class I in schizophrenia. | Handel AE et al. | β | 2010 | β |
| The psychosis susceptibility gene ZNF804A: associations, functions, and phenotypes. | Donohoe G et al. | β | 2010 | β |
| The pursuit of genome-wide association studies: where are we now? | Ku CS et al. | β | 2010 | β |
| The role of genetics in the etiology of schizophrenia. | Gejman PV et al. | β | 2010 | β |
| Uncovering the roles of rare variants in common disease through whole-genome sequencing. | Cirulli ET et al. | β | 2010 | β |
| Whole genome association studies in complex diseases: where do we stand? | Need AC et al. | β | 2010 | β |
| A vertebrate Polycomb response element governs segmentation of the posterior hindbrain. | Sing A et al. | β | 2009 | β |
| Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. | Datwani A et al. | β | 2009 | β |
| Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges. | Williams M | β | 2009 | β |
| Common variants conferring risk of schizophrenia. | Stefansson H et al. | β | 2009 | β |
| Common variants in polygenic schizophrenia. | Glessner JT et al. | β | 2009 | β |
| Copy-number variants in neurodevelopmental disorders: promises and challenges. | Merikangas AK et al. | β | 2009 | β |
| Genetic overlap between autism, schizophrenia and bipolar disorder. | Carroll LS et al. | β | 2009 | β |
| Genetics of anxiety disorders: the complex road from DSM to DNA. | Smoller JW et al. | β | 2009 | β |
| Linkage and association studies of anxiety disorders. | Hamilton SP | β | 2009 | β |
| Meta-analysis of genome-wide association studies with overlapping subjects. | Lin DY et al. | β | 2009 | β |
| MHC class I: an unexpected role in neuronal plasticity. | Shatz CJ | β | 2009 | β |
| Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. | Doi N et al. | β | 2009 | β |
| Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. | Sebat J et al. | β | 2009 | β |
| Schizophrenia: the "BLOC" may be in the endosomes. | Ryder PV et al. | β | 2009 | β |
| The role of DNA copy number variation in schizophrenia. | Tam GW et al. | β | 2009 | β |
| A classification of sociomedical health indicators: perspectives for health administrators and health planners. | Siegmann AE | β | 1976 | β |